The REVIVED-BCIS2 trial: percutaneous coronary intervention vs. optimal medical therapy for stable patients with severe ischaemic cardiomyopathy.
Rocco VergalloGiovanna LiuzzoPublished in: European heart journal (2022)
Keyphrases
- percutaneous coronary intervention
- st segment elevation myocardial infarction
- acute coronary syndrome
- acute myocardial infarction
- st elevation myocardial infarction
- coronary artery disease
- phase iii
- antiplatelet therapy
- study protocol
- healthcare
- coronary artery bypass grafting
- phase ii
- heart failure
- clinical trial
- early onset
- coronary artery bypass
- open label
- drug induced
- left ventricular
- double blind